10-K/A

FORM 10-K AMENDMENT 1

Company: CNS Pharmaceuticals, Inc.
Filed: April 29, 2022
Period of Report: December 31, 2021
Accession Number: 0001683168-22-003055

View Document ↗ View on SEC.gov ↗